ORAL MUCOSAL FORMULATIONS OF ASPIRIN
Application
US20260090985A1
Kind: A1
Apr 02, 2026
Inventors
James Dzandu
Abstract
Disclosed herein, in part, are pharmaceutical formulations for oral mucosal (e.g., sublingual and/or buccal) administration comprising micronized aspirin, (e.g., 91 mg to 200 mg micronized aspirin), a buffer, a surfactant, and one or more pharmaceutically acceptable excipients, wherein the pH of a solution of the formulation dissolved in 1 mL distilled water is less than or equal to 3. Methods of treating a subject in need thereof comprising administering one or more disclosed pharmaceutical formulations to the subject are also provided herein.
CPC Classifications
A61K 9/006
A61K 9/1611
A61K 9/1617
A61K 9/1629
A61K 31/192
A61P 9/04
Filing Date
2025-10-02
Application No.
19348728